Stem Cell Therapy Improves Outcomes in Severe Heart Failure

April 5, 2016

(Eurekalert) – A new stem cell therapy significantly improved long-term health outcomes in patients with severe and end-stage heart failure in a study presented at the American College of Cardiology’s 65th Annual Scientific Session. Among 109 patients randomized to receive the cell therapy or a placebo, those receiving the cell therapy, which involved extracting stem cells from a patient’s own bone marrow, showed a 37 percent lower rate of the trial’s primary endpoint, a composite of deaths, cardiovascular hospitalizations and clinic visits for sudden worsening of heart failure symptoms, over a 12-month period.

Recommended Reading